Patent · US Active

Transdermal delivery systems

US8956644B2 · kind B2 · utility

12Cited by
165References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2012
Grant dateFeb 17, 2015
Priority date—
Expiry dateNov 16, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are bupivacaine transdermal delivery systems, and related methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.